Lv11
64 积分 2024-03-05 加入
Belantamab mafodotin, a BCMA-directed antibody-drug conjugate for multiple myeloma
4天前
已完结
Decoding immunotherapy resistance in multiple myeloma: genetic insights and approaches to counter resistance
4天前
已完结
Antibody-drug conjugates in hematologic malignancies
6天前
已完结
Update of antibody-drug conjugates for hematological malignancies
6天前
已完结
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges
6天前
已完结
Linker Design for the Antibody Drug Conjugates: A Comprehensive Review
6天前
已完结
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma
1个月前
已完结
Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications
1个月前
已完结
Pre-Hematopoietic Cell Transplant Ruxolitinib in Transplant-Eligible Patients with Myelofibrosis: Long-Term Outcomes of a Phase II Prospective Study
10个月前
已关闭
皖公网安备34019202002308
